第一作者:
Bhawna,Sirohi
第一单位:
Department of Medical Oncology, Mazumdar Shaw Cancer Centre, Narayana Health, Bangalore, India.
作者:
主题词
氨基吡啶类(Aminopyridines);动物(Animals);抗肿瘤药(Antineoplastic Agents);乳腺肿瘤(Breast Neoplasms);临床试验, Ⅰ期(主题)(Clinical Trials, Phase I as Topic);临床试验, Ⅱ期(主题)(Clinical Trials, Phase II as Topic);药物评价, 临床前(Drug Evaluation, Preclinical);女(雌)性(Female);人类(Humans);吗啉类(Morpholines);磷酸肌醇3-激酶类(Phosphatidylinositol 3-Kinases);蛋白激酶抑制剂(Protein Kinase Inhibitors);原癌基因蛋白质c-akt(Proto-Oncogene Proteins c-akt);信号传导(Signal Transduction);TOR丝氨酸-苏氨酸激酶(TOR Serine-Threonine Kinases);治疗结果(Treatment Outcome)
DOI
10.2217/fon.15.56
PMID
25963424
发布时间
2021-12-03
- 浏览73
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文